{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-24-000037","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2024-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.636696+00:00","generated_at":"2026-05-31T17:37:04.159612+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tenet Q2 Net Income $259M, Adj EPS $2.31; Raises FY 2024 EBITDA, FCF Outlook","bullets":["Q2 net income $259M ($2.64 diluted EPS), up from $123M ($1.15) YoY; adjusted EPS $2.31.","Consolidated Adjusted EBITDA $945M (+12.1% YoY); Ambulatory Care EBITDA $447M (+20.8%).","New $1.5B share repurchase authorization; completed prior $1B program with 4.8M shares bought in H1 2024.","FY 2024 Adjusted EBITDA guidance raised to $3.825-3.975B (+$300M); FCF outlook raised to $1.1-1.35B (+$150M).","Same-hospital admissions up 5.2% vs Q2 2023; same-facility ambulatory surgical cases +0.2% with net rev/case +6.8%."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-24-000037","json":"https://secwatch.observer/filing/0000070318-24-000037.json","markdown":"https://secwatch.observer/filing/0000070318-24-000037.md","text":"https://secwatch.observer/filing/0000070318-24-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000037/0000070318-24-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000037/thc-20240724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T17:37:04.159612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}